Skip to main content
Premium Trial:

Request an Annual Quote

GeneNews Raises $6.7M in Private Placement

NEW YORK (GenomeWeb) – GeneNews today announced it has accepted subscriptions for a non-brokered private placement of its common shares for gross proceeds of about C$7.2 million (US$6.7 million).

The Toronto-based molecular diagnostics shop will issue 7 million common shares at C$1.03 per share as a result of the placement, which GeneNews announced last week. In a statement, GeneNews Executive Chairman James Howard-Tripp said that the financing provides the company with the resources to build out Innovative Diagnostics Laboratory "as a strong commercialization outlet" for the firm's molecular diagnostic tests for colon cancer, lung cancer, and prostate cancer.

IDL is a CLIA laboratory jointly owned by GeneNews, Health Diagnostics Laboratory, and an unnamed US sales organization.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.